Regado Biosciences Inc 4
4 · Regado Biosciences Inc · Filed Jan 3, 2014
Insider Transaction Report
Form 4
Zelenkofske Steven
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2014-01-01+75,000→ 75,000 totalExercise: $4.77Exp: 2023-12-31→ Common Stock, par value $0.001 per share (75,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest as to 25% of the shares underlying the option on the one-year anniversary of the date of grant and as to the remaining 75% of the shares underlying the option in equal monthly installments over the subsequent 36 months on the last day of each month.